TC Medical(SH:600763) Xin Lang Ji Jin·2026-02-02 02:26Group 1 - The core viewpoint of the news is that Tongce Medical's stock has increased by 5%, reaching a price of 48.30 yuan per share, with a trading volume of 481 million yuan and a turnover rate of 2.25%, resulting in a total market capitalization of 21.604 billion yuan [1] - Tongce Medical Co., Ltd. is located in Hangzhou, established on August 30, 1995, and listed on October 30, 1996. The company's main business involves medical service investment and dental medical services [1] - The revenue composition of Tongce Medical is as follows: medical services account for 92.84%, product sales 4.06%, construction engineering 2.72%, and others 0.38% [1] Group 2 - From the perspective of the top ten circulating shareholders of Tongce Medical, Huabao Fund holds a position in the top ten shareholders, with the Huabao CSI Medical ETF (512170) reducing its holdings by 1.5804 million shares in the third quarter, now holding 8.8854 million shares, which represents 1.99% of the circulating shares [2] - The Huabao CSI Medical ETF (512170) was established on May 20, 2019, with a latest scale of 25.263 billion yuan. Year-to-date return is 4.77%, ranking 2834 out of 5579 in its category; the one-year return is 14.49%, ranking 3655 out of 4285; and since inception, the return is 6.66% [2] - The fund manager of Huabao CSI Medical ETF is Hu Jie, who has a cumulative tenure of 13 years and 113 days, with the total asset scale of 101.358 billion yuan. The best fund return during his tenure is 162.35%, while the worst is -98.01% [2]